The AI and Semiconductor potential reckoning that has gripped Wall Street all month came to a head last week as the biggest names in the group finally stepped up to report earnings, and the market’s response was brutal as many of these strong earnings reports were aggressively sold into. Throw in worries in the Middle East and the Bond Market and it turned out to be a bad setup for stocks. For the week, the Nasdaq bore the brunt with a drop of roughly 2.1%, while the S&P 500 slipped 0.6%, the Dow eased 0.4%, and the Russell 2000 fell 1.1%.

The AI and Semiconductor potential reckoning that has gripped Wall Street all month came to a head last week as the biggest names in the group finally stepped up to report earnings, and the market’s response was brutal as many of these strong earnings reports were aggressively sold into. Throw in worries in the Middle East and the Bond Market and it turned out to be a bad setup for stocks. For the week, the Nasdaq bore the brunt with a drop of roughly 2.1%, while the S&P 500 slipped 0.6%, the Dow eased 0.4%, and the Russell 2000 fell 1.1%.

The AI and Semiconductor potential reckoning that has gripped Wall Street all month came to a head last week as the biggest names in the group finally stepped up to report earnings, and the market’s response was brutal as many of these strong earnings reports were aggressively sold into. Throw in worries in the Middle East and the Bond Market and it turned out to be a bad setup for stocks. For the week, the Nasdaq bore the brunt with a drop of roughly 2.1%, while the S&P 500 slipped 0.6%, the Dow eased 0.4%, and the Russell 2000 fell 1.1%.

As growth investors, we continue to advise a cautious but flexible stance, as our neutral-to-negative growth-focused indicators and the weak action among many leading stocks has us holding lots of cash. That said, we’re really not that negative--most big-picture evidence is still positive, and our watch list is still full of stocks holding in normally while the market finds its way. We have no changes tonight, but are ready to pounce when our indicators give the go-ahead.

Before we dive into this week’s covered call idea we need to clean up a couple positions from the July expiration cycle. First off, FROG, BROS and SN expired for their full profits. However, SEDG and FLEX did not, leaving us with our stock positions which we will exit today.

To execute these trades, you need to:

Sell SEDG Stock

Sell FLEX Stock

Moving on …

The split tape condition we alluded to last week continues to hold sway, with a divergence of strength and weakness among the major sectors. While there are some encouraging signs among key groups—including financials, healthcare and cybersecurity—the primary evidence is still mixed, with cross-currents holding sway and some growth-y names looking for support. Accordingly, we’ll keep our Market Monitor at level 6.

This week’s list has a fair number of stocks that should be able to shake off—or even benefit from—the latest headwinds. Our Top Pick is showing solid momentum and has excellent potential with a promising healthcare franchise.

Midsummer market malaise drags on, but perhaps that will change in the coming weeks now that second-quarter earnings season is in full swing. And while air has certainly come out of the balloon of the AI trade of late, money has mostly rotated into sectors and names that either didn’t participate in or sharply trailed the massive market run-up in April and May. That includes today’s new addition to the Cabot Stock of the Week portfolio. It’s an undervalued healthcare name that I recommended to my Cabot Value Investor readers last month. So far, it’s looking like a smart buy-low choice, as the stock is starting to build momentum. And yet, shares remain undervalued – making it perfect for the current risk-off climate.

Details inside.

The semiconductor selloff went from a sector story to the market’s main event last week, as the Philadelphia Semiconductor Index (SOX) tumbled into a bear market — down 20% from its recent highs — while investors continued to question whether the enormous sums being poured into AI infrastructure will earn their keep. Adding to the drama, oil surged nearly 10% as the fragile U.S.-Iran ceasefire wobbled yet again. The encouraging news is that a cool June CPI report (inflation data) and strong results from the big banks kept money rotating — into energy, financials and consumer staples — rather than fleeing stocks altogether.

The semiconductor selloff went from a sector story to the market’s main event last week, as the Philadelphia Semiconductor Index (SOX) tumbled into a bear market — down 20% from its recent highs — while investors continued to question whether the enormous sums being poured into AI infrastructure will earn their keep. Adding to the drama, oil surged nearly 10% as the fragile U.S.-Iran ceasefire wobbled yet again. The encouraging news is that a cool June CPI report (inflation data) and strong results from the big banks kept money rotating — into energy, financials and consumer staples — rather than fleeing stocks altogether.

The semiconductor selloff went from a sector story to the market’s main event last week, as the Philadelphia Semiconductor Index (SOX) tumbled into a bear market — down 20% from its recent highs — while investors continued to question whether the enormous sums being poured into AI infrastructure will earn their keep. Adding to the drama, oil surged nearly 10% as the fragile U.S.-Iran ceasefire wobbled yet again. The encouraging news is that a cool June CPI report (inflation data) and strong results from the big banks kept money rotating — into energy, financials and consumer staples — rather than fleeing stocks altogether.

As I expected, SpaceX (SPCX) shares have fallen below their 135 IPO price, marking a significant decline from their initial highs above 200.

Earnings growth has accounted for more than 70% of the S&P 500’s total return since the 1990s, with the rest coming from dividends and changes in valuation. The five largest banks in the United States this week posted a combined $49 billion in profit for the last quarter, shattering records amidst increased investment in AI and a surge in related deals.

The July Issue of Cabot Early Opportunities focuses on three companies helping power some of today’s most important industrial growth markets – from aerospace and nuclear energy to infrastructure and specialty materials.

These businesses are benefiting from powerful long-term demand trends, yet all three remain far less followed than many of today’s market favorites. Recent pullbacks toward key moving averages have created attractive entry points as their growth stories continue to unfold.

All the details are inside this month’s Issue.

It’s not often that we discuss currencies in the Cabot Turnaround Letter, but given the persistent relative strength of the U.S. dollar right now, I think it’s imperative that we address it—mainly because of how it will likely impact our portfolio holdings going forward.

The top haven asset for the first half of 2026 wasn’t gold, U.S. Treasury bonds or the Japanese yen.

After spending much of the year leading the market higher, small caps have finally run into a little turbulence. Through midday today, the S&P 600 Index is down 1.8% from last Thursday’s close, roughly in line with the S&P 500’s 1.9% decline.

That said, it’s important to keep the recent pullback in perspective. Small caps remain the market’s clear leader in 2026, with the S&P 600 up 20.2% year to date versus an 8.1% gain for the S&P 500.

While flashier, more star-studded teams like Lionel Messi’s Argentina, Kylian Mbappe’s France and Erling Haaland’s Norway garnered most of the headlines at the just-completed World Cup, Spain was the best team. There was nothing flashy about Spain: no mega-stars, not a ton of goals, no relentless attack. Instead, they dominated the tournament with precision passing, immaculate ball control and near-impenetrable (just one goal allowed all tournament!) defense.

High-flying AI-related stocks are facing a high bar of performance. Even what normally would be considered staggering growth is met with a yawn. The backdrop of the Middle East conflict and almost $100 oil is not helpful.

The Philadelphia Semiconductor Index (SOX) has outperformed the S&P 500 by 57% this year, even after a sharp correction. This is basically a macro trade, and there are few industries as cyclical, or as capital-intensive, as semiconductor manufacturing.

The market rolls sideways amidst a slew of conflicting forces.

The S&P 500 has bounced around and is at the same level it was in the middle of May. The primary culprit is technology. That sector has been in a funk. The S&P 500 is hard-pressed to generate any lasting traction while this massive sector, accounting for over 40% of the index, flounders.

The market has gone sideways since May. It seems to be deciding what to do.

It’s encouraging that the resumption of hostilities with Iran has not sent the market lower. It’s also positive that oil prices aren’t rising back to the $100 level earlier in the war, although prices have risen. It’s also another earnings season and analysts expect a big one.

With war being one of the most dominant themes of the last four years, it stands to reason that investors should position their portfolios to account for this conspicuous (and unwelcome) trend.

And lest one be tempted to think that the warfare theme will diminish anytime soon, last week’s article by NPR deflates that illusion: It revealed that global military conflicts are at their highest level since WWII.

Price targets are standard practice on Wall Street. But sometimes, they can act as an artificial ceiling.

For example, say Truist sets a price target on an up-and-coming growth stock that’s 25% higher than its current share price. For a growth stock, a 25% return isn’t much. But then again, the stock could be a total flop, which is the natural boom-or-bust tradeoff growth investors must endure in trading off increased risk for massive upside. So, a price target on a growth stock seems almost like an unnecessary cap on a stock that has the potential to go through the roof.

WHAT TO DO NOW: Continue to trim your sails. In the Model Portfolio, we’ve been getting closer and closer to shore as growth funds and indexes are under pressure and AI stocks cascade lower. Tonight we’re going to further trim Marvell (MRVL) given its ugly action, selling a third of what we have left. That will leave the portfolio with a big 58% cash position. We could put some of that to work if growth names find support, but we want to see key growth measures firm up before buying.

After a brief pause last week, small caps are once again leading the pack.

Through Wednesday’s close, the S&P 600 Small Cap Index is up roughly 21% year to date, compared to gains of about 15% for the S&P 400 MidCap Index, 17% for the Nasdaq and 11% for the S&P 500.

Its earnings season again! That’s a good thing. Earnings just might save the day in an otherwise confusing and uncertain market.

The market is causing whiplash. The Iran peace deal changed things. Stocks held back by high oil prices, and the resulting higher inflation and interest rates, reignited as oil prices came back down after the peace deal. But hostilities with Iran have resumed.

The peace deal may be on hold again. But stocks are hanging in there so far.

The ceasefire with Iran is over and hostilities have resumed. That sounds like a bigger bummer than it’s been in the market so far. Falling oil prices enabled previously beleaguered stocks to soar higher again as the prognosis for inflation and interest rates simultaneously improved. But that rally is over if oil prices spike higher again.

Today’s recommendation, from Todd Johnson, is a turnaround story for long-term investors.

Rite Aid (RAD)
from Dividend Lab

Rite Aid is the nation’s third-largest drugstore chain with 4,604 stores (as of August 31, 2013) and about $25 billion in annual revenues. Rite Aid fills about 297 million scripts each year and has about...

Today’s buy idea is an out-of-favor value play from one of our newest contributors, Carl Delfeld.

Royal Gold (RGLD)
from The Value Bounce

A number of events have brought gold stocks, and RGLD with them, down sharply, as its share price is down 38.8% so far in 2013. Some reasons include:

• The pullback in...

Today’s Daily Alert features a new small-cap recommendation and an update on one of our Top Picks for 2013.

Solta Medical (SLTM)
from The Cheap Investor

Solta Medical is a global leader in the medical aesthetics market providing ... aesthetic energy devices for skin resurfacing and rejuvenation, acne reduction, body contouring and skin...

Update

Google (GOOG)
from $100k Portfolio, chosen as a Top Pick for 2013 at $733 in Investment Digest issue 734, dated January 9, 2013.

Google shares are finally getting the respect they deserve.

On October 17, the company reported a great quarter. The results sent shares soaring 14% in a single trading session. And the stock...

Today we have a new buy and a sell from Stephen Leeb.

Twenty-First Century Fox (FOXA)
from The Complete Investor

Twenty-First Century Fox is one of the two companies created when Rupert Murdoch’s News Corp. split itself into two, and it got all the fast-growing media and content assets. It’s arguably the most...

NVR Inc. (NVR)
from The Complete Investor, recommended at $903 in Investment Digest issue 729, dated October 24, 2012.

We’re selling three picks whose performance hangs more on macro considerations than on hard metrics like free cash flow. ... NVR, whose business model makes it a standout among housing stocks, was the...

Today John Reese recommends a stock that scores well on his tests of both earnings growth and value characteristics.

Bridgepoint Education (BPI)
from Validea Hot List

Strategy: Price/Sales Investor

Based on: Kenneth Fisher

Bridgepoint Education is a provider of postsecondary education services. The company’s academic institutions include Ashford University and University of the Rockies. Its...

Today we have a concise retail sector recommendation, followed by updates on Eagle Bancorp (EGBN) and DreamWorks (DWA).

Ulta Salon, Cosmetics & Fragrance (ULTA)
from US Investment Report

In retailing our newest pick is oddly-named Ulta Salon Cosmetics & Fragrance (ULTA) of Bolingbrook, IL. Call it a beauty retailer, if you will. With...

Update

Eagle Bancorp (EGBN)
from Upside, recommended at $15 in Investment Digest issue 715, dated March 14, 2012

Eagle Bancorp retreated 4.3% today despite posting solid September-quarter results. Per-share earnings were $0.44, up 10% and a penny above the consensus. Revenue, which consists of net interest income and noninterest income, also rose 10% and...

Sell Alert

DreamWorks Animation (DWA)
from The Primary Trend, recommended at $24 in Investment Digest issue 696, dated June 1, 2011.

We have sold DreamWorks Animation (DWA). Its 50%-plus move since the spring, culminating with “good news” on its Netflix deal, gave us an opportunity to get out while the getting’s good. Sell...

Today’s new buy idea is an energy stock that just surged higher after reporting better-than-expected third quarter results. The stock has pulled back slightly from its post-earnings high, creating a good buying opportunity for new investors.

Core Laboratories (CLB)
from Blue Chip Growth

Oil companies are finding it increasingly difficult to extract...

Today’s new idea comes from value guru J. Royden Ward. You’ll receive your October Investment Digest issue this afternoon.

Portfolio Recovery Associates (PRAA)
from Cabot Benjamin Graham Value Investor

Portfolio Recovery Associates (PRAA) purchases, manages and collects defaulted consumer receivables from credit originators such as banks. The company either buys the receivables...

A few Cabot Options Trader subscribers have asked me about ways to protect gains in their portfolios, so I thought I would write to everyone with a couple of strategies using options to hedge your portfolio.

A subscriber recently asked me if I keep a journal of my trades. Many traders keep journals so they can look back at their trades and evaluate what they did right and what they did wrong.

Want to know how the big institutional investors use options? Here is an example of how one trader spent $132 million on three technology stocks.

Options trading has its own vernacular. To know how to do it, you need to know what every options term means. Here are some of the basics.

Our Cabot Momentum Trader’s market timing system consists of two parts—one based on the action of three select, growth-oriented market indexes, and the other based on the action of the fast-moving stocks Cabot Momentum Trader features.